Investor profile
Boehringer Ingelheim Venture Fund (BIVF) has backed 5 European tech companies across 5 funding rounds between 2022 and 2026, joining rounds totalling €52M. Most active in Healthtech. Data as of 6 Aug 2026.
Also recorded as: the Boehringer Ingelheim Venture Fund (BIVF)
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Brainomix | UK | 1 | €17M |
| Aignostics | Germany | 1 | €14M |
| tacalyx | Germany | 1 | €11M |
| Refoxy Pharmaceuticals | Germany | 1 | €9.1M |
| smartbax | Germany |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Brainomix | Series C | €17M | 2025-03 |
| Aignostics | Series A | €14M | 2022-09 |
| tacalyx | Seed | €11M | 2026-04 |
| Refoxy Pharmaceuticals |
| 1 |
| €1.2M |
| Seed |
| €9.1M |
| 2024-12 |
| smartbax | Seed | €1.2M | 2023-05 |
